ロード中...
Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia
Prophylactic donor lymphocyte infusion (pDLI) could reduce relapse in patients with refractory/relapsed acute leukemia (RRAL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but optimal timing of pDLI remains uncertain. We compared the outcomes of two strategies for pDLI b...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7966710/ https://ncbi.nlm.nih.gov/pubmed/33747904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.554503 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|